Ngm Biopharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Pierce Valerie L

Rieflin William Jl

Viret Jean-Frederic

Woodhouse David J

News Filter

Bio Announces Closing of Tender Offer

Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Bio Has Entered Into a Definitive Agreement and Plan of Merger With Certain Affiliates of the Column Group, LP

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Notice of effectiveness